Large deletions in the first intron of WNK1 leads to an elevation in WNK1 expression causing an autosomal dominant disease called pseudohypoaldosteronism type II (PHA II; OMIM #145260) or Gordon's syndrome [13], [14]. Here, WNK1 is linked to Gordon syndrome.